ArticleThe Journal of clinical investigation2021

Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth.

Michael D Nyquist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.